Post on 12-Jun-2015
transcript
PAIN and ANALGESIA
www.freelivedoctor.com
Experimental evidence that nociceptive fibersare distinct from other sensory fibers
www.freelivedoctor.com
A-delta vs. C fibers
A-delta: myelinated; intermediate velocity (20m/s)C: unmyelinated; slower velocity (2m/s); polymodal
www.freelivedoctor.com
AnterolateralPathway
www.freelivedoctor.com
1. Lissauer’s tract2. substantia gelatinosa3. nucleus proprius4. anterior commissure5. anterolateral tract
www.freelivedoctor.com
2 sensory pathways:Anterolateral
andDorsal Column
www.freelivedoctor.com
3 Types of Pain:
www.freelivedoctor.com
Free Nerve Ending
www.freelivedoctor.com
1. Tissue damage leads to release of inflammatory/sensitizing agents:bradykinin, protons, histamine, PGE2, nerve growth factor
2. Bind receptors (TrkA, EP), leads to G-protein cascade, releasing PKA, PKC
3. PKA phosphorylates Nav1.8/1.9; PKC phosphorylates noxious stimuli receptors (TRPV, ASIC)
4. Result: increased ion influx per depolarization; lowered activation threshold
Peripheral Sensitization
www.freelivedoctor.com
www.freelivedoctor.com
Central Sensitization
1. At presynapse(s), glutamate release, plus substance P,CGRP, BDNF
2. Bind to postsynaptic AMPA, NMDA, mGluR, NK1,trigger ion influx and depolarization, or to signal cascadethat activates kinases
3. Immediate: phosphorylation of AMPA receptorsincreases glutamate signaling; phosphorylation of NMDArelieves Mg2+ block
4. Later: phosphorylation of gene regulatory proteinscan alter gene expression (e.g. DREAM, a repressor ofthe endogenous opioid dynorphin, is activated)
www.freelivedoctor.com
Analgesia
Analgesia = absence of pain sensationAnesthesia = absence of sensation
Analgesic possibilities suggested by anterolateral tract:
- inhibitors of Na+ channels (anticonvulsants, local anesthetics, etc.)- inhibitors of inflammatory mediators (NSAIDS, etc.)- inhibitors of NMDA receptors (NMDA antagonists)- inhibitors of other targets: AMPA, Nav1.8/1.9, NK1, TRPV, etc.
www.freelivedoctor.com
Pain Modulation:
- Descending Pathway- Inhibitory Interneurons (Gate Theory)
www.freelivedoctor.com
Overview of Descending Pathways:
Midbrain
Pons
Medulla
www.freelivedoctor.com
Inhibitory Neurotransmission
1. Inhibitory interneurons or descendingprojections release various NTs: GABA, NE, or endogenous opioids
2. Bind receptors on presynapse ofafferent pain fiber, inhibit Ca2+ channels,leading to reduced vesicle release
3. Also bind post-synaptically: can signalvia G-proteins to cause K+ efflux orCl- influx (both are hyperpolarizing)
www.freelivedoctor.com
Opioids
Clinically: morphine, codeine, oxycodone, fentanyl, methadone, (heroin)
Endogenous:
beta-endorphins: mu receptors 1 & 2 (endogenous morphine)enkephalins: delta receptorsdynorphins: kappa receptors
Receptor Location:mu: supraspinal (insula, amygdala, hypothalamus, PAG, medulla)kappa: spinal corddelta: spinal cord and supraspinal
www.freelivedoctor.com
Ongoing studies to determineconditions leading to endogenousopioid release. Emotional statesseem to play a role, especiallyfear/stress as relates to pain.
Some implicated areas:PAG, medulla, cingulate, nucleusaccumbens
www.freelivedoctor.com
Opioid agonists, like morphine, have broader systemic effects due to opioid receptors in other siginificant areas:
- chemoreceptor trigger zone (CTZ) in medullary area postrema- vomiting center in medullary lateral reticular formation- respiratory control center in medulla- GI tract
www.freelivedoctor.com
Summary: Analgesic Targets
www.freelivedoctor.com
Sources:
- Purves Neuroscience textbook- Pharm textbook- Woolf lecture notes & articles- Rainville paper cited in Purves’s ‘Pain’ chapter
www.freelivedoctor.com